CTOs on the Move

Terumo Medical Corp

www.terumo-europe.com

 
Terumo Medical Corp is a Somerset, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Transtech Medical Solutions

Transtech Medical Solutions, LLC is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Baptist Hospital

Baptist Hospital, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Baptist Hospital, Inc. is based in Nashville, TN. You can find more information on Baptist Hospital, Inc. at www.baptisthospital.com

South Florida Baptist Hospital

South Florida Baptist Hospital, Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. South Florida Baptist Hospital, Inc is based in Plant City, FL. You can find more information on South Florida Baptist Hospital, Inc at www.sjbhealth.org

Valley Eldercare Ctr-Valley

Valley Eldercare Ctr-Valley is a Grand Forks, ND-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.